3,235
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

A comparison of the heating characteristics of capacitive and radiative superficial hyperthermia

&
Pages 378-386 | Received 01 Aug 2016, Accepted 01 Dec 2016, Published online: 08 Jan 2017

References

  • Cihoric N, Tsikkinis A, van Rhoon G, et al. (2015). Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia 31:609–14.
  • Overgaard J, González González D, Hulshof MCCM, et al. (1995). Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 345:540–43.
  • Vernon CC, Hand JW, Field SB, et al. (1996). Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731–44.
  • de Bruijne M, van der Holt B, van Rhoon GC, van der Zee J. (2010). Evaluation of CEM43 degrees CT90 thermal dose in superficial hyperthermia: a retrospective analysis. Strahlenther Onkol 186:436–43.
  • Sapareto SA, Dewey WC. (1984). Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10:787–800.
  • Hand JW, Lagendijk JJ, Bach Andersen J, Bolomey JC. (1989). Quality assurance guidelines for ESHO protocols. Int J Hyperthermia 5:421–8.
  • van Rhoon GC. (2016). Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperthermia 32:50–62.
  • Abe M, Hiraoka M, Takahashi M, et al. (1986). Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 58:1589–95.
  • Gabriele P, Ferrara T, Baiotto B, et al. (2009). Radio hyperthermia for re-treatment of superficial tumours. Int J Hyperthermia 25:189–98.
  • Puric E, Heuberger J, Lomax N, Timm O. (2009). The benefit of thermoradiotherapy in the treatment of superficially localized tumors: experience with Bsd 500 microwave hyperthermia system. Strahlenther Onkol 185:648.
  • Oldenborg S, Griesdoorn V, van Os R, et al. (2015). Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: size matters. Radiother Oncol 117:223–28.
  • Masunaga S, Hiraoka M, Takahashi M, et al. (1990). Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer – comparison of results with radiotherapy alone. Int J Hyperthermia 6:487–97.
  • Kok HP, Wust P, Stauffer PR, et al. (2015). Current state of the art of regional hyperthermia treatment planning: a review. Radiat Oncol 10:196.
  • Kok HP, De Greef M, Van Wieringen N, et al. (2010). Comparison of two different 70 MHz applicators for large extremity lesions: simulation and application. Int J Hyperthermia 26:376–88.
  • de Bruijne M, Wielheesen DH, Van der Zee J, et al. (2007). Benefits of superficial hyperthermia treatment planning: five case studies. Int J Hyperthermia 23:417–29.
  • Kroeze H, Kokubo M, van de Kamer JB, et al. (2002). Comparison of a capacitive and a cavity slot radiative applicator for regional hyperthermia. Jpn J Hyperthermic Oncol 18:75–91.
  • De Bree J. (1998). A 3-D anatomy based treatment planning system for interstitial hyperthermia [PhD thesis]. Utrecht University.
  • Gelvich EA, Mazokhin VN. (2002). Contact flexible microstrip applicators (CFMA) in a range from microwaves up to short waves. IEEE Trans Biomed Eng 49:1015–23.
  • Kok HP, De Greef M, Correia D, et al. (2009). FDTD simulations to assess the performance of CFMA-434 applicators for superficial hyperthermia. Int J Hyperthermia 25:462–76.
  • Kok HP, Correia D, De Greef M, et al. (2010). SAR deposition by curved CFMA-434 applicators for superficial hyperthermia: measurements and simulations. Int J Hyperthermia 26:171–84.
  • Oncotherm. (2016). http://www.oncotherm.com/.
  • Celsius42+. (2016). http://www.celsius42.de/.
  • Kroeze H, van de Kamer JB, de Leeuw AA, et al. (2003). Treatment planning for capacitive regional hyperthermia. Int J Hyperthermia 19:58–73.
  • Hornsleth SN, Mella O, Dahl O. (1996). A new segmentation algorithm for finite difference based treatment planning systems. In: Franconi C, Arcangeli G, Cavaliere R, eds. Hyperthermic oncology 1996. vol. 2. Rome, Italy: Tor Vergata, 521–23.
  • Taflove A, Hagness SC. (2000). Computational electrodynamics. 2nd ed. Boston, London: Artech House.
  • Berenger JP. (1994). “A perfectly matched layer for the absorption of electromagnetic-waves”. J Comput Phy 114:185–200.
  • de Bree J, van der Koijk JF, Lagendijk JJW. (1996). A 3-D SAR model for current source interstitial hyperthermia. IEEE Trans Biomed Eng 43:1038–45.
  • Gabriel S, Lau RW, Gabriel C. (1996). The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol 41:2251–69.
  • ESHO Taskgroup Committee. (1992). Treatment planning and modelling in hyperthermia, a Task Group Report of the European Society for Hyperthermic Oncology. Rome, Italy: Tor Vergata.
  • Pennes HH. (1948). Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1:93–122.
  • Rhee JG, Lee CK, Osborn J, et al. (1991). Precooling prevents overheating of subcutaneous fat in the use of RF capacitive heating. Int J Radiat Oncol Biol Phys 20:1009–15.
  • van Rhoon GC, van der Zee J, Broekmeyer-Reurink MP, et al. (1992). Radiofrequency capacitive heating of deep-seated tumours using pre-cooling of the subcutaneous tissues: results on thermometry in Dutch patients. Int J Hyperthermia 8:843–54.
  • Huilgol NG, Gupta S, Dixit R. (2010). Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia 26:21–5.
  • Li G, Mitsumori M, Ogura M, et al. (2004). Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. Int J Clin Oncol 9:179–83.
  • Myerson RJ, Perez CA, Emami B, et al. (1990). Tumor control in long-term survivors following superficial hyperthermia. Int J Radiat Oncol Biol Phys 18:1123–9.
  • van der Zee J, van der Holt B, Rietveld PJ, et al. (1999). Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer 79:483–90.
  • Reddy NM, Shanta V, Krishnamurthi S. (1986). On minimisation of toxicity to skin during capacitive radio-frequency hyperthermia. Br J Radiol 59:1129–31.
  • Griffiths H, Ahmed A, Smith CW. (1984). Power loss in skin cooling pillows during RF hyperthermia. Br J Radiol 57:254–6.
  • Brezovich IA, Lilly MB, Durant JR, Richards DB. (1981). A practical system for clinical radiofrequency hyperthermia. Int J Radiat Oncol Biol Phys 7:423–30.
  • Sherar M, Liu FF, Pintilie M, et al. (1997). Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 39:371–80.
  • Oleson JR, Samulski TV, Leopold KA, et al. (1993). Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 25:289–97.
  • Leopold KA, Dewhirst MW, Samulski TV, et al. (1993). Cumulative minutes with T(90) greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys 25:841–7.